Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression
Open Access
- 15 October 2002
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (22) , 14404-14409
- https://doi.org/10.1073/pnas.222537099
Abstract
Colony-stimulating factor-1 receptor (CSF-1R) is the major regulator of macrophage development and is associated with epithelial cancers of the breast and ovary. Immunohistochemistry analysis of murine prostate development demonstrated epithelial expression of CSF-1R during the protrusion of prostatic buds from the urogenital sinus, during the prepubertal and androgen-driven proliferative expansion and branching of the gland, with a decline in older animals. Models of murine prostate cancer showed CSF-1R expression in areas of carcinoma- and tumor-associated macrophages. Several human prostate cancer cell lines and primary cultures of human prostate epithelial cells had low but detectable levels of CSF-1R. Human prostatectomy samples showed low or undetectable levels of receptor in normal glands or benign prostatic hypertrophy specimens. Staining was strongest in areas of prostatic intraepithelial neoplasia or carcinoma of Gleason histological grade 3 or 4. The activated form of the receptor reactive with antibodies specific for phosphotyrosine modified peptide sequences was observed in samples of metastatic prostate cancer. Immunohistochemistry showed strong expression of CSF-1R by macrophage lineage cells, including villous macrophages and the syncytiotrophoblast layer of placenta, Kupper cells in the liver, and histiocytes infiltrating near prostate cancers. These observations correlate CSF-1R expression with changes in the growth and development of the normal and neoplastic prostate.Keywords
This publication has 58 references indexed in Scilit:
- Osteolysis and cancerJournal of Clinical Investigation, 2001
- Phase I Pilot Trial of the Bispecific Antibody MDXH210 (anti-FcγRI X anti–HER-2/neu) in Patients Whose Prostate Cancer Overexpresses HER-2/neuJournal of Immunotherapy, 2001
- Anticancer drug targets: growth factors and growth factor signalingJournal of Clinical Investigation, 2000
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibodyOncogene, 1997
- CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tractMolecular Reproduction and Development, 1997
- Distribution of the CD68 macrophagr/myeloid associated antigenInternational Immunology, 1990
- The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor geneNature, 1990
- Transforming potential of the c-fms proto-oncogene (CSF-1 receptor)Nature, 1987
- The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1Cell, 1985